-
Alfacalcidol
Japanese Name: アルファカルシドール
Pharmacopoeia: BP/EP
CAS Number: 41294-56-8
CDMF No.: Y20180000715
Molecular Formula: C27H44O2
Molecular Weight: 400.6 g/mol
Clinical Indications: Osteoporosis, Chronic renal insufficiency, Hypoparathyroidism, Vitamin D-resistant rickets, Osteomalacia
-
Calcifediol
Japanese Name: カルシフェジオール
Pharmacopoeia: BP/EP/USP
CAS Number: 63283-36-3
CDMF No.: To be registered
Molecular Formula: C27H46O2
Molecular Weight: 418.7 g/mol
Clinical Indications: Osteoporosis, Rickets, Osteomalacia
-
Calcipotriene
Japanese Name: カルシポトリオール
Pharmacopoeia: BP/EP/JP
CAS Number: 147657-22-5
CDMF No.: Y20200001036
Molecular Formula: C27H40O3•H2O
Molecular Weight: 430.600 g/mol
Clinical Indications: Psoriasis Vulgaris
-
Calcitriol
Japanese Name: カルシトリオール
Pharmacopoeia: BP/EP/USP
CAS Number: 32222-06-3
CDMF No.: Y20210000028
Molecular Formula: C27H42O2
Molecular Weight: 416.600 g/mol
Clinical Indications: Rickets, Osteoporosis, Hypoparathyroidism, Renal osteodystrophy, Osteomalacia
-
Doxercalciferol
Japanese Name: ドキセルカルシフェロール
Pharmacopoeia: USP
CAS Number: 54573-75-0
CDMF No.: Y20180001141
Molecular Formula: C28H44O2
Molecular Weight: 412.600 g/mol
Clinical Indications: Secondary hyperparathyroidism
-
Eldecalcitol
Japanese Name: エルデカルシトール
Pharmacopoeia: Enterprise standard
CAS Number: 104121-92-8
CDMF No.: Y20210000737
Molecular Formula: C30H50O5
Molecular Weight: 490.700 g/mol
Clinical Indications: Osteoporosis
-
Ketorolac tromethamine
Japanese Name: ケトロラクトロメタミン
Pharmacopoeia: ChP/USP
CAS Number: 74103-07-4
CDMF No.: Y20210000317
Molecular Formula: C19H24N2O6
Molecular Weight: 376.400 g/mol
Clinical Indications: Short-term (up to 5 days in adults), management of moderately severe acute pain that requires analgesia at the opioid level
-
Thioctic Acid Trometamol
Synonym: Lipoic acid tromethamine
Japanese Name: リポ酸トロメタミン
Pharmacopoeia: /
CAS Number: 62-46-4
CDMF No.: Y20200000812
Molecular Formula: C8H14O2S2·C4H11NO3
Molecular Weight: 327.460 g/mol
Clinical Indications: Vascular stress in patients with diabetes
-
Maxacalcitol
Japanese Name: マキサカルシトール
Pharmacopoeia: JP
CAS Number: 103909-75-7
CDMF No.: To be registered
Molecular Formula: C26H42O4
Molecular Weight: 418.618 g/mol
Clinical Indications: Secondary hyperparathyroidism, Psoriasis
-
Paricalcitol
Japanese Name: パリカルシトール
Pharmacopoeia: USP
CAS Number: 131918-61-1
CDMF No.: To be registered
Molecular Formula: C27H44O3
Molecular Weight: 416.646 g/mol
Clinical Indications: Secondary hyperparathyroidism
-
Regadenoson
Japanese Name: レガデノソン
Pharmacopoeia: /
CAS Number: 313348-27-5
USDMF No.: 036679
CDMF No.: Y20200000551
Molecular Formula: C15H18N8O5
Molecular Weight: 390.350 g/mol
Clinical Indications: Pharmacologic stress agent indicated for radionuclide myocardial perfusion imaging (MPI) in patients unable to undergo adequate exercise stress.
-
Tacalcitol monohydrate
Japanese Name: タカルシトール
Pharmacopoeia: BP/EP/JP
CAS Number: 93129-94-3
CDMF No.: Y20180001179
Molecular Formula: C27H44O3•H2O
Molecular Weight: 434.661 g/mol
Clinical Indications: Psoriasis Vulgaris
